Announcement on Semi-annual Performance for 2026
Filed with SSE · · 2 pages · Chinese
On 6ix: 6ix.com/news/tasly-pharmaceutical-group-co-ltdannouncement-on-semi-annual-performance-for-2026
Tasly Pharmaceutical Group Co. Ltd. on 6ix
Earlier from Tasly Pharmaceutical
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Announcement on Obtaining Drug Registration Certificate by Subsidiary
- Announcement on Remuneration Plan for Directors and Senior Management Members in 2026
- Announcement on Implementation of Dividend Distribution for 2025
- Announcement on Convening Performance Briefing for 2025 and Q1 2026
Later from Tasly Pharmaceutical
- Announcement on a Wholly-owned Subsidiary's Receipt of Clinical Trial Notice for the Extension of the Treatment Time Window for the Acute Ischemic Stroke Indication of Recombinant Human Pro-urokinase for Injection
- Announcement on Amendments to the Articles of Association
- Announcement on Subsidiary Obtaining the Notice of Approval for Clinical Trial
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Announcement on Attending the 2026 Online Collective Reception Day for Investors of Listed Companies in Tianjin Jurisdiction
Follow Tasly Pharmaceutical into a list and get an email when it puts out news.
Follow Tasly Pharmaceutical